Tivic Health Systems Receives Three New Patents From USPTO And EPO; Advances In Bioelectronic Medicine
Portfolio Pulse from Benzinga Newsdesk
Tivic Health Systems has received three new patents from the USPTO and EPO, advancing its bioelectronic medicine technology. The patents cover adaptive triggers for microcurrent stimulation devices and dynamic voltage adjustments for sinus treatment devices, enhancing device performance and user experience.
July 23, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tivic Health Systems has received three new patents from the USPTO and EPO, which protect its innovative bioelectronic medicine technologies. These patents are likely to enhance the company's product offerings and market position.
The new patents protect Tivic Health Systems' innovative technologies, which are likely to improve device performance and user experience. This advancement can enhance the company's product offerings and strengthen its market position, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100